Hannah Fry
VP, Controller · Protara Therapeutics, Inc.
Individual
- 2026
- Jan 27, 2026
- 3
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Hannah Fry files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jesse Shefferman - $882K in TARA purchases and sales in the last 12 months
- Jacqueline Zummo - $125K in TARA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Hannah Fry?
Hannah Fry is a corporate insider, tracked as VP, Controller of Protara Therapeutics, Inc. (TARA). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Hannah Fry last file a Form 4?
The most recent primary Form 4 on record is dated 27 January 2026, one of 3 filings going back to 2026.
